Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.

Cancer Manag Res · 2021 · PMC8643129 · PMID 34876852

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the correlation did not reach statistical significance (possibly due to small numbers), the direction of the effect potentially supports our hypothesis that cytopenia would truly correlate with improved outcomes after CAR-T therapy (data not shown).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.